ATAgata Tomaszewska

Agata Tomaszewska

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Agata Tomaszewska has a total of 40 co-authors. Here are the top co-authors by number of shared publications:

  • Agnieszka Krupa

    Department of Immunology and Infectious Biology, Faculty of Biology and Environmental Protection, University of Lodz, Banacha 12/16, 90-237 Lodz, Poland

    7 shared publications
  • Andrzej Pawlak

    Centre of Molecular and Macromolecular Studies, Polish Academy of Sciences, Sienkiewicza 112, 90-363 Lodz, Poland

    2 shared publications
  • Bartosz Kopka

    Centre of Molecular and Macromolecular Studies, Polish Academy of Sciences, Sienkiewicza 112, 90-363 Lodz, Poland

    2 shared publications
  • Bartłomiej Kost

    Centre of Molecular and Macromolecular Studies, Polish Academy of Sciences, Sienkiewicza 112, 90-363 Lodz, Poland

    2 shared publications
  • Magdalena Chmiela

    Department of Immunology and Infectious Biology, Faculty of Biology and Environmental Protection, University of Lodz, Lodz, Poland

    2 shared publications
  • Magdalena Chmiela

    Department of Immunology and Infectious Biology, Institute of Microbiology, Biotechnology and Immunology, Faculty of Biology and Environmental Protection, University of Lodz, Banacha 12/16, 90-237 Lodz, Poland

    2 shared publications

Latest Publications

  • Open Access

    Gaultheria procumbens L. Fractionated Leaf Extracts and Wintergreen Essential Oil: A Direct Comparison of Their Antioxidant and Immunomodulatory Activities in Immune Cells and Human Plasma In Vitro

    by Piotr Michel, Joanna Kołodziejczyk-Czepas, Marcin Włodarczyk, Agnieszka Krupa, Małgorzata Siwińska, Karolina Skrobacz, Agata Tomaszewska, Marta Krzyżaniak, Monika Anna Olszewska

    Gaultheria procumbens L. leaves and wintergreen essential oil have traditionally been used to relieve pain and inflammation; however, the relative contributions of their chemically distinct non-volatile and volatile fractions to these effects remain poorly understood. This study directly compared the antioxidant and immunomodulatory activities of polyphenol-rich leaf extracts and leaf essential oil (LEO) obtained from the same batch of plant material. Fractionated extracts and LEO were chemically characterised using UHPLC-PDA-ESI-MS/MS, HPLC-PDA, GC-FID-MS, and spectrophotometric assays, and their biological effects were evaluated using human plasma and immune cell-based models, including peroxynitrite (ONOO−)-exposed plasma, stimulated peripheral blood mononuclear cells (PBMCs), THP1-Blue™ NF-κB cells, and human monocyte-derived macrophages. Fractionation markedly enriched the extracts in polyphenols, reaching 646.7 mg gallic acid equivalents/g dry weight in the ethyl acetate fraction (EAF), whereas LEO consisted predominantly of methyl salicylate (99.8%). Among the tested preparations, EAF showed the most consistent antioxidant protection of plasma components against ONOO−-induced damage. At 50 μg/mL, EAF decreased IL-6 and increased IL-10 levels in stimulated PBMCs, whereas LEO did not significantly affect either cytokine. EAF also showed the strongest inhibition of LPS-induced NF-κB activation. In resting M0 macrophages the methanol-water extract and LEO elicited a partial M1-like response, primarily reflected by increased IL-6. Overall, the results show distinct biological profiles for the volatile and non-volatile fractions of G. procumbens leaves, with broader antioxidant and immunomodulatory effects predominantly associated with non-volatile polyphenols. These findings indicate that non-volatile polyphenol-rich fractions are major contributors to the biological activity of G. procumbens leaves, although in vivo confirmation is required.

  • Open Access

    Targeted and safe delivery of colchicine via polymeric nanocarriers for potential atherosclerosis therapy with in vitro and in vivo evaluation

    by Agata Tomaszewska, Bartłomiej Kost, Marek Brzeziński, Martyna Nowicka, Maja Krupa, Tomasz Rechciński, Łucja Balcerzak, Sława Glińska, Magdalena Chmiela, Agnieszka Krupa

    This study highlights the potential of nanoparticle-encapsulated colchicine as a safer and more effective alternative to free colchicine for treating atherosclerotic vascular disease (ASCVD). While colchicine is known for its anti-inflammatory properties, its dose-dependent toxicity limits long-term clinical use. To address this issue, colchicine was encapsulated in polymeric nanoparticles synthesized through a microfluidic method using methylated β-cyclodextrin as the initiator. The resulting formulation achieved an encapsulation efficiency of 30% and a drug loading capacity of 75%, indicating a high payload capability. This approach not only demonstrated high drug-loading efficiency but also enabled controlled release, with approximately 60% of the drug being released over 96 h. The nanoparticle formulation preserved colchicine’s ability to inhibit foam cell formation—a critical event in the progression of atherosclerosis—while significantly reducing toxicity to eukaryotic cells. Transmission electron microscopy revealed that cells treated with nanoparticle-bound colchicine maintained normal morphology, unlike those exposed to free colchicine, which rapidly accumulates intracellularly and disrupts cell function. In vivo evaluation confirmed the safety of the formulation, showing no adverse effects on the liver, kidneys, or heart, as indicated by stable levels of ALT, AST, creatinine, and cardiac troponin I. Biodistribution studies with fluorescently labeled nanoparticles further suggested accumulation in tissues such as the heart and liver, highlighting the potential therapeutic relevance of colchicine-loaded nanoparticles for cardiovascular applications. Given these findings, the nanoparticle-based colchicine formulation presents a favorable efficacy and safety profile, warranting further preclinical development and eventual clinical evaluation.


  • Biocompatible, porous hydrogels composed of aliphatic polyesters and poly(2-isopropenyl-2-oxazoline). Their application as scaffolds for bone tissue regeneration

    by Bartosz Kopka, Bartłomiej Kost, Andrzej Pawlak, Irena Bąk-Sypień, Marek Brzeziński, Agata Tomaszewska, Agnieszka Krupa, Piotr Jóźwiak, Malgorzata Basko

    In this study, porous networks were efficiently prepared by crosslinking hydrophilic poly(2-isopropenyl-2-oxazoline) (PiPOx) with dicarboxylic polyesters (HOOC–PLA–COOH or HOOC–PCL–COOH) in the presence of sodium chloride as a water-soluble porogen. Importantly, by using a relatively simple synthetic protocol, the resulting spongy materials were freely formed to the desired size and shape while maintaining stable dimensions. According to the SEM data, the porous 3D structure can be altered by the pore dimensions, which are dependent on the porogen crystal size. After porosity characterization, the mechanical properties were also evaluated via uniaxial compression and tensile tests. The porous networks formed hydrogels with a high water absorption capacity. Finally, after showing cytocompatibility by the MTT assay, we also demonstrated the applicability of the porous hydrogels as scaffolds for cell cultivation. The presented results suggest that this type of hydrogels is a promising material for tissue engineering.


  • Open Access

    Helicobacter pylori components increase the severity of metabolic syndrome and its hepatic manifestations induced by a high fat diet

    by Agata Tomaszewska, Weronika Gonciarz, Tomasz Rechcinski, Magdalena Chmiela, Anna K. Kurdowska, Agnieszka Krupa

    The metabolic syndrome, often accompanied by hepatic manifestations, is a high-risk factor for developing cardiovascular disease. Patients with metabolic dysfunction associated with steatohepatic disease (MASDL) are at significant risk of developing coronary artery disease. Atherosclerosis is a systemic inflammatory disorder in which several factors, including dietary or infectious factors, can cause an inflammatory response. Helicobacter pylori (HP) bacteria have been implicated in the progression of proatherogenic vascular endothelial lesions, moreover, our previous study in an experimental in vivo model of Cavia porcellus showed that HP components and high-fat substances acted synergistically in promoting vascular endothelial inflammation, leading to an early onset of a proatherogenic environment. In the present study, our goal was to determine the contribution of HP components to the development of hepatic manifestations of metabolic syndrome in an experimental model. Our results showed that HP infection in animals exposed to a high-fat diet increased oxidative stress and lipid peroxidation, followed by endothelial lipid deposition, impaired endothelial apoptosis, cell lysis, and increased vascular stiffness. Finally, histopathological analysis of liver tissue showed signs of MASLD development in HP-infected animals fed a high-fat diet.


  • Covalent segmented polymer networks composed of poly(2-isopropenyl-2-oxazoline) and selected aliphatic polyesters: designing biocompatible amphiphilic materials containing degradable blocks

    by Bartosz Kopka, Bartłomiej Kost, Andrzej Pawlak, Agata Tomaszewska, Agnieszka Krupa, Malgorzata Basko

    To promote facile and efficient synthesis of segmented covalent networks, we developed a cross-linking process with reactive polymeric components in a system without catalysts or side products. To achieve the direct formation of amphiphilic networks, an addition reaction was performed between the polyesters containing carboxyl terminal groups with pendant groups distributed along poly(2-isopropenyl-2-oxazoline) chains. Covalent cross-linking was achieved from predetermined amounts of components dissolved in DMSO at 140 °C. To tune the properties of the resulting networks, the composition and length of the polyester segments and the degree of cross-linking were changed in the feed. The chemical structure of the networks was characterized using Fourier transform infrared-attenuated total reflection spectroscopy and 13C magic-angle spinning NMR. The swelling ability of the formed networks was investigated in aqueous and organic media. Moreover, mechanical properties were tested during uniaxial compression. The cytocompatibility of the scaffolds was confirmed by MTT assay. Through the results obtained, the first report describing the cross-linking of polyesters on hydrophilic PiPOx was provided to prepare new, biocompatible materials with tuneable properties that are promising for potential biomedical applications.


  • Open Access

    Clindamycin-Loaded Nanosized Calcium Phosphates Powders as a Carrier of Active Substances

    by Dagmara Słota, Karina Piętak, Wioletta Florkiewicz, Josef Jampilek, Agnieszka Tomala, Mateusz M. Urbaniak, Agata Tomaszewska, Karolina Rudnicka, Agnieszka Sobczak-Kupiec

    Bioactive calcium phosphate ceramics (CaPs) are one of the building components of the inorganic part of bones. Synthetic CaPs are frequently used as materials for filling bone defects in the form of pastes or composites; however, their porous structure allows modification with active substances and, thus, subsequent use as a drug carrier for the controlled release of active substances. In this study, four different ceramic powders were compared: commercial hydroxyapatite (HA), TCP, brushite, as well as HA obtained by wet precipitation methods. The ceramic powders were subjected to physicochemical analysis, including FTIR, XRD, and determination of Ca/P molar ratio or porosity. These techniques confirmed that the materials were phase-pure, and the molar ratios of calcium and phosphorus elements were in accordance with the literature. This confirmed the validity of the selected synthesis methods. CaPs were then modified with the antibiotic clindamycin. Drug release was determined on HPLC, and antimicrobial properties were tested against Staphylococcus aureus. The specific surface area of the ceramic has been demonstrated to be a factor in drug release efficiency.


  • Open Access

    Antibodies towards TVLLPVIFF Amino Acid Sequence of TNF Receptor Induced by Helicobacter pylori in Patients with Coronary Heart Disease

    by Weronika Gonciarz, Agata Tomaszewska, Agnieszka Krupa, Tomasz Rechciński, Maciej Chałubiński, Marlena Broncel, Magdalena Chmiela

    Background: Molecular mimicry between Helicobacter pylori (Hp) and the host components resulting in induction of cross-reacting antibodies has been suggested as accessory mechanism in the development of coronary heart disease (CHD). A potential target for antibodies induced during Hp infection by the components of these bacteria might be amino acid sequence TVLLPVIFF (P1) of tumor necrosis factor receptor (TNFR), which is exposed on vascular endothelium and immunocompetent cells, driving inflammation. Aim: To examine whether anti-P1 IgG are induced during Hp infection in CHD patients. Methods: Sera from CHD patients infected with Hp (54) vs. sera of uninfected healthy donors (22) were tested by the ELISA for anti-H. pylori antibodies, anti-P1 IgG, and for antibodies towards control sequence IAKEGFEKIS (P2). Sera of Caviae porcellus infected experimentally with Hp (30) or uninfected (10) were included into this study. The same serum samples, which were positive for anti-P1 IgG, were adsorbed with Hp and then subjected to the ELISA. The biological activity of anti-P1 IgG was assessed in complement (C1q) binding assay. Results: Sera of 43 CHD patients seropositive for anti-Hp IgG contained anti-P1 IgG binding C1q. Additionally, 10 serum samples of animals seropositive for anti-Hp IgG contained anti-P1 IgG. Anti-P1 IgG in tested sera were neutralized by their adsorption with Hp. Conclusion: In CHD patients infected with Hp, antibodies cross-reacting with TNFR common sequence are produced. Further studies are necessary to define immunogenic Hp determinants and to confirm possible cellular effects of cross-reacting antibodies.


  • Open Access

    Interference of LPS H. pylori with IL-33-Driven Regeneration of Caviae porcellus Primary Gastric Epithelial Cells and Fibroblasts

    by Weronika Gonciarz, Agnieszka Krupa, Anthony P. Moran, Agata Tomaszewska, Magdalena Chmiela

    Background: Lipopolysaccharide (LPS) of Helicobacter pylori (Hp) bacteria causes disintegration of gastric tissue cells in vitro. It has been suggested that interleukin (IL)-33 is involved in healing gastric injury. Aim: To elucidate whether Hp LPS affects regeneration of gastric barrier initiated by IL-33. Methods: Primary gastric epithelial cells or fibroblasts from Caviae porcellus were transfected with siRNA IL-33. Such cells, not exposed or treated with LPS Hp, were sub-cultured in the medium with or without exogenous IL-33. Then cell migration was assessed in conjunction with oxidative stress and apoptosis, activation of extracellular signal-regulated kinase (Erk), production of collagen I and soluble ST2 (IL-33 decoy). Results: Control cells not treated with LPS Hp migrated in the presence of IL-33. The pro-regenerative activity of IL-33 was related to stimulation of cells to collagen I production. Wound healing by cells exposed to LPS Hp was inhibited even in the presence of IL-33. This could be due to increased oxidative stress and apoptosis in conjunction with Erk activation, sST2 elevation and modulation of collagen I production. Conclusions: The recovery of gastric barrier cells during Hp infection potentially can be affected due to downregulation of pro-regenerative activity of IL-33 by LPS Hp.